Search

Search Constraints

You searched for: Author/Creator Cubillo, A.

Search Results

1. 2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population pharmacokinetics (PK) and its association with efficacy and safety in patients with solid tumors based on the phase 3 study NAPOLI-1 and five phase 1 and 2 studies. (September 2015)

2. 361 Phase I, open-label, dose-escalating clinical and pharmacokinetic study of the novel antimicrotubulin agent PM060184 administered over 10 minutes on days 1-3 and 15-17 every 28 days to patients with advanced malignant solid tumors. (September 2015)

5. OC-0414 Stereotactic body radiotherapy: neoadjuvant strategy of chemoradiation in pancreatic adenocarcinoma. (August 2021)